TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Faron Pharmaceuticals Oy
Closing information (x1000 DKK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
8,572
|
3,880
|
6,745 |
Financial expenses |
2,684
|
2,321
|
1,087 |
Earnings before taxes |
-68,538
|
-45,863
|
-10,014 |
Total assets |
128,518
|
110,597
|
28,358 |
Current assets |
85,332
|
82,592
|
1,802 |
Current liabilities |
32,488
|
16,394
|
12,374 |
Equity capital |
80,909
|
83,412
|
-4,981 |
- share capital |
20,006
|
20,081
|
20,035 |
Employees (average) |
10
|
6
|
5 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
63.0%
|
75.4%
|
-17.6% |
Turnover per employee |
857
|
647
|
1,349 |
Profit as a percentage of turnover |
-799.6%
|
-1182.0%
|
-148.5% |
Return on assets (ROA) |
-51.2%
|
-39.4%
|
-31.5% |
Current ratio |
262.7%
|
503.8%
|
14.6% |
Return on equity (ROE) |
-84.7%
|
-55.0%
|
201.0% |
Change turnover |
4,706
|
-2,880 | |
Change turnover % |
122%
|
-43% | |
Chg. No. of employees |
4
|
1 | |
Chg. No. of employees % |
67%
|
20% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.